SCHEMBL3171606

SCHEMBL3171606

CC(=O)NCCNc1cc(NCCNC(=O)CNC(=O)c2ccc(Cl)cc2)nc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
MALT1 Q9UDY8 1/20 0.44
MMP1 P03956 1/20 0.41
POLB P06746 1/20 0.41
GPR139 Q6DWJ6 1/20 0.41
GABRA5 P31644 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LTA4H P09960 1/20 0.39
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39
NCSTN Q92542 1/20 0.39
APH1A Q96BI3 1/20 0.39
PSENEN Q9NZ42 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3164769 0.95 GPR139 (0.46) ADORA3SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL3175682 0.93 ADORA3 (0.50) ADORA3SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL3176983 0.89 ADORA3 (0.57) ADORA3SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL3163156 0.88 RAB9A (0.48) ADORA3SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL3172697 0.87 NPC1 (0.47) ADORA3SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL3175775 0.87 ADORA3 (0.48) ADORA3SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL3175971 0.86 ADORA3 (0.56) ADORA3SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL3170553 0.86 TP53 (0.53) ADORA3SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL3163297 0.86 NPC1 (0.55) ADORA3SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL3171192 0.86 ADORA3 (0.47) ADORA3SMN1; SMN2NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed